AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 22011557 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivabradine in long-term β-blocker therapy
Number of subjects: 120
Study 22011557 — intervention group
Group type: COMPARATOR
Intervention: Metoprolol in long-term β-blocker therapy
Number of subjects: 120
Study 19284124 — intervention group
Group type: EXPERIMENTAL
Intervention: Seated in the direction of the long axis of the table, heels resting on the table
Number of subjects: 168
Study 19284124 — intervention group
Group type: COMPARATOR
Intervention: Seated perpendicular to the long axis of the table, legs hanging from the table
Number of subjects: 168
Study 19284124 — intervention group
Group type: COMPARATOR
Intervention: Left lateral decubitus position
Number of subjects: 168
Study 17465661 — intervention group
Group type: EXPERIMENTAL
Intervention: SEP Clearfil S3 Bond after one light cure
Number of subjects: 75
Study 17465661 — intervention group
Group type: EXPERIMENTAL
Intervention: SEP Clearfil S3 Bond after two light cures
Number of subjects: 75
Study 17465661 — intervention group
Group type: EXPERIMENTAL
Intervention: Adper Prompt L‐Pop after one light cure
Number of subjects: 75
Study 17465661 — intervention group
Group type: EXPERIMENTAL
Intervention: Adper Prompt L‐Pop after two light cures
Number of subjects: 75
Study 17465661 — intervention group
Group type: COMPARATOR
Intervention: Transbond Plus
Number of subjects: 75
Study 17465661 — intervention group
Group type: EXPERIMENTAL
Intervention: SEP Adper Prompt L‐Pop
Number of subjects: 75
Study 17465661 — intervention group
Group type: EXPERIMENTAL
Intervention: SEP Clearfil S3 Bond light cured together with adhesive
Number of subjects: 75
Study 17465661 — intervention group
Group type: EXPERIMENTAL
Intervention: SEP Clearfil S3 Bond light cured separately from adhesive
Number of subjects: 75
Study 15074085 — intervention group
Group type: EXPERIMENTAL
Intervention: Angelica Injection (AI)
Number of subjects: 1404
Study 15074085 — intervention group
Group type: COMPARATOR
Intervention: Compound salvia
Number of subjects: 1404
Study 15074085 — intervention group
Group type: COMPARATOR
Intervention: Low molecular dextran injection
Number of subjects: 1404
Study 12083500 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulodexide
Number of subjects: 235
Study 12083500 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 235
Study 9534081 — intervention group
Group type: EXPERIMENTAL
Intervention: High-carbohydrate diet (75 +/- 8% CHO, n = 6)
Number of subjects: 12
Study 9534081 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-carbohydrate diet (7 +/- 4% CHO, n = 6)
Number of subjects: 12
Study 12799862 — intervention group
Group type: EXPERIMENTAL
Intervention: Verum acupuncture (correct point location, normal prick depth, elicitation of needle sensation)
Number of subjects: 81
Study 12799862 — intervention group
Group type: COMPARATOR
Intervention: Control acupuncture (points far from acupuncture points, superficial prick technique, no needle sensation)
Number of subjects: 81
Study 2125546 — intervention group
Group type: EXPERIMENTAL
Intervention: Monophasic preparation (150 micrograms LNG and 30 micrograms EE)
Number of subjects: 45
Study 2125546 — intervention group
Group type: EXPERIMENTAL
Intervention: Triphasic preparation (low doses of LNG and EE in various proportions)
Number of subjects: 45
Study 2125546 — intervention group
Group type: COMPARATOR
Intervention: IUD users
Number of subjects: 45
Study 6793373 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual nitroglycerin 0.5 mg
Number of subjects: 0
Study 6793373 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral nitroglycerin 6.5 mg
Number of subjects: 0
Study 6793373 — intervention group
Group type: COMPARATOR
Intervention: Placebo tablet
Number of subjects: 0
Study 29087367 — intervention group
Group type: EXPERIMENTAL
Intervention: PVP plus I seed
Number of subjects: 169
Study 29087367 — intervention group
Group type: EXPERIMENTAL
Intervention: PVP plus RT
Number of subjects: 169
Study 29087367 — intervention group
Group type: EXPERIMENTAL
Intervention: PVP plus RFA
Number of subjects: 169
Study 29087367 — intervention group
Group type: EXPERIMENTAL
Intervention: PVP plus ZA
Number of subjects: 169
Study 29197834 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 20 mg per day
Number of subjects: 200
Study 29197834 — intervention group
Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 200
Study 25699296 — intervention group
Group type: EXPERIMENTAL
Intervention: Bovine bone graft‐1
Number of subjects: 8
Study 25699296 — intervention group
Group type: EXPERIMENTAL
Intervention: Bovine bone graft‐2
Number of subjects: 8
Study 25223171 — intervention group
Group type: EXPERIMENTAL
Intervention: Bushen Tiaojing Recipe (BTR) + controlled ovarian hyperstimulation (COH)
Number of subjects: 60
Study 25223171 — intervention group
Group type: COMPARATOR
Intervention: Controlled ovarian hyperstimulation (COH) alone
Number of subjects: 60
Study 23217036 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based health management
Number of subjects: 2400
Study 23217036 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 2400
Study 20181815 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 microg Se-yeast/d
Number of subjects: 119
Study 20181815 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 microg Se-yeast/d
Number of subjects: 119
Study 20181815 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 microg Se-yeast/d
Number of subjects: 119
Study 20181815 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 microg Se-enriched onions/d
Number of subjects: 119
Study 20181815 — intervention group
Group type: COMPARATOR
Intervention: Control (unenriched onion meals)
Number of subjects: 119
Study 20181815 — intervention group
Group type: EXPERIMENTAL
Intervention: All selenium intervention groups
Number of subjects: 119
Study 16802196 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose alcohol
Number of subjects: 115
Study 16802196 — intervention group
Group type: COMPARATOR
Intervention: Sober participants
Number of subjects: 115
Study 16802196 — intervention group
Group type: COMPARATOR
Intervention: Mildly intoxicated participants
Number of subjects: 115
Study 15725050 — intervention group
Group type: EXPERIMENTAL
Intervention: Respimat Soft Mist Inhaler (SMI)
Number of subjects: 245
Study 15725050 — intervention group
Group type: COMPARATOR
Intervention: Hydrofluoroalkane metered dose inhaler (HFA-MDI)
Number of subjects: 245
Study 15725050 — intervention group
Group type: EXPERIMENTAL
Intervention: Respimat SMI
Number of subjects: 245
Study 15725050 — intervention group
Group type: EXPERIMENTAL
Intervention: Respimat SMI and HFA-MDI
Number of subjects: 245
Study 12011296 — intervention group
Group type: EXPERIMENTAL
Intervention: Pramipexole (PPX) at doses of 1.5 mg/d and 4.5 mg/d
Number of subjects: 0
Study 12011296 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 12011296 — intervention group
Group type: EXPERIMENTAL
Intervention: Pramipexole (PPX)
Number of subjects: 0
Study 10216808 — intervention group
Group type: EXPERIMENTAL
Intervention: Eprosartan (200 mg b.i.d. to 300 mg b.i.d.)
Number of subjects: 40
Study 10216808 — intervention group
Group type: COMPARATOR
Intervention: Enalapril (5 mg o.d. to 20 mg o.d.)
Number of subjects: 40
Study 10216808 — intervention group
Group type: EXPERIMENTAL
Intervention: Eprosartan + Hydrochlorothiazide (HCTZ) (12.5‐25 mg o.d. added if SitDBP > or = 90 mmHg)
Number of subjects: 40
Study 10216808 — intervention group
Group type: COMPARATOR
Intervention: Enalapril + Hydrochlorothiazide (HCTZ)
Number of subjects: 40
Study 7797830 — intervention group
Group type: EXPERIMENTAL
Intervention: ursodeoxycholic acid
Number of subjects: 56
Study 7797830 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 56
Study 2129650 — intervention group
Group type: EXPERIMENTAL
Intervention: enprostil 70 micrograms b.d.
Number of subjects: 98
Study 2129650 — intervention group
Group type: COMPARATOR
Intervention: ranitidine 150 mg b.d.
Number of subjects: 98
Study 359216 — intervention group
Group type: EXPERIMENTAL
Intervention: Nefopam 30 mg
Number of subjects: 122
Study 359216 — intervention group
Group type: EXPERIMENTAL
Intervention: Nefopam 60 mg
Number of subjects: 122
Study 359216 — intervention group
Group type: EXPERIMENTAL
Intervention: Nefopam 90 mg
Number of subjects: 122
Study 359216 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin 325 mg
Number of subjects: 122
Study 359216 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin 650 mg
Number of subjects: 122
Study 359216 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 122
Study 30476529 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive verbal feedback
Number of subjects: 90
Study 30476529 — intervention group
Group type: COMPARATOR
Intervention: No verbal feedback (Control)
Number of subjects: 90
Study 28110111 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT)
Number of subjects: 208
Study 28110111 — intervention group
Group type: COMPARATOR
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 208
Study 26707295 — intervention group
Group type: EXPERIMENTAL
Intervention: preemptive CTA (pCTA) group - donors underwent CTA at least 60 days before nephrectomy
Number of subjects: 86
Study 26707295 — intervention group
Group type: COMPARATOR
Intervention: delayed CTA (dCTA) group - donors underwent CTA within 3 days before nephrectomy
Number of subjects: 86
Study 23341426 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulphur homeopathic remedy (6c, 12c, 30c)
Number of subjects: 96
Study 23341426 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsatilla homeopathic remedy (6c, 12c, 30c)
Number of subjects: 96
Study 23341426 — intervention group
Group type: COMPARATOR
Intervention: Distilled water (control)
Number of subjects: 96
Study 23341426 — intervention group
Group type: COMPARATOR
Intervention: Water-ethanol (95%) solution (control)
Number of subjects: 96
Study 21813916 — intervention group
Group type: EXPERIMENTAL
Intervention: QC
Number of subjects: 39
Study 21813916 — intervention group
Group type: EXPERIMENTAL
Intervention: QFO
Number of subjects: 39
Study 21813916 — intervention group
Group type: COMPARATOR
Intervention: P
Number of subjects: 39
Study 19089448 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-based group treatment
Number of subjects: 80
Study 19089448 — intervention group
Group type: COMPARATOR
Intervention: Individual treatment
Number of subjects: 80
Study 16816280 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychotherapy sessions
Number of subjects: 248
Study 15585045 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 minutes of moderate intensity cycling (experimental)
Number of subjects: 20
Study 15585045 — intervention group
Group type: COMPARATOR
Intervention: 10 minutes of very light intensity cycling (control)
Number of subjects: 20
Study 11265558 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 1094
Study 9562345 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive therapy
Number of subjects: 1441
Study 9562345 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 1441
Study 9562345 — intervention group
Group type: COMPARATOR
Intervention: Combined cohorts (Intensive vs Conventional)
Number of subjects: 1441
Study 9562311 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin 990 mg/day + Dipyridamole 225 mg/day
Number of subjects: 1306
Study 9562311 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1306
Study 2708928 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous methylprednisolone
Number of subjects: 20
Study 2708928 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 3891 — intervention group
Group type: EXPERIMENTAL
Intervention: Kö 1366 (bunitrolol)
Number of subjects: 20
Study 3891 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 31165402 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic Roux-en-Y gastric bypass (LRYGB)
Number of subjects: 43
Study 31165402 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic sleeve gastrectomy (LSG)
Number of subjects: 43
Study 31165402 — intervention group
Group type: COMPARATOR
Intervention: LRYGB and LSG
Number of subjects: 43
Study 28258090 — intervention group
Group type: EXPERIMENTAL
Intervention: Vildagliptin (50mg)
Number of subjects: 25
Study 28258090 — intervention group
Group type: COMPARATOR
Intervention: Placebo (for Vildagliptin)
Number of subjects: 25
Study 28258090 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (850mg)
Number of subjects: 25
Study 28258090 — intervention group
Group type: COMPARATOR
Intervention: Placebo (for Metformin)
Number of subjects: 25
Study 25359384 — intervention group
Group type: EXPERIMENTAL
Intervention: RVmIVS pacing
Number of subjects: 22
Study 25359384 — intervention group
Group type: EXPERIMENTAL
Intervention: RVOT pacing
Number of subjects: 22
Study 25359384 — intervention group
Group type: COMPARATOR
Intervention: Cardiac resynchronization therapy (CRT)
Number of subjects: 22
Study 23944945 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate nasal drops (FPND)
Number of subjects: 60
Study 23944945 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional endoscopic sinus surgery (FESS)
Number of subjects: 60
Study 23944945 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined therapy of FPND and FESS
Number of subjects: 60
Study 21333458 — intervention group
Group type: EXPERIMENTAL
Intervention: COMBOHP (combination high protein diet; 0.92% creatine monohydrate and 2.75% dextrose with minimum 16% crude protein)
Number of subjects: 48
Study 21333458 — intervention group
Group type: EXPERIMENTAL
Intervention: COMBO (combination diet; 0.92% creatine monohydrate and 2.75% dextrose)
Number of subjects: 48
Study 21333458 — intervention group
Group type: COMPARATOR
Intervention: CON (control; basal diet consisting of a ground corn‐soybean base)
Number of subjects: 48
Study 19803567 — intervention group
Group type: EXPERIMENTAL
Intervention: Norwegian Universal Preventive Program for Social Anxiety (NUPP‐SA)
Number of subjects: 1748
Study 19803567 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 1748
Study 16892780 — intervention group
Group type: EXPERIMENTAL
Intervention: Asthma education (AE) program after an ED visit
Number of subjects: 239
Study 16892780 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 239
Study 15275840 — intervention group
Group type: EXPERIMENTAL
Intervention: Squatting during descent
Number of subjects: 23
Study 15275840 — intervention group
Group type: COMPARATOR
Intervention: Inhibited squatting
Number of subjects: 23
Study 15275840 — intervention group
Group type: EXPERIMENTAL
Intervention: Release angle of 5 degrees
Number of subjects: 23
Study 15275840 — intervention group
Group type: EXPERIMENTAL
Intervention: Release angle of 12 degrees
Number of subjects: 23
Study 11641592 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg of amphetamine combined with physiotherapy for 10 sessions over 5 weeks
Number of subjects: 39
Study 11641592 — intervention group
Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 39
Study 9128822 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxitropium bromide 375 micrograms
Number of subjects: 20
Study 9128822 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxitropium bromide 750 micrograms
Number of subjects: 20
Study 9128822 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxitropium bromide 1500 micrograms
Number of subjects: 20
Study 9128822 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 9128822 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenoterol 400 micrograms
Number of subjects: 20
Study 7967408 — intervention group
Group type: EXPERIMENTAL
Intervention: Small central capsulotomy without dilating the pupil
Number of subjects: 20
Study 7967408 — intervention group
Group type: COMPARATOR
Intervention: Large capsulotomy through dilated pupils
Number of subjects: 20
Study 3189262 — intervention group
Group type: EXPERIMENTAL
Intervention: Intragastric provocation under endoscopic control (IPEC)
Number of subjects: 30
Study 3189262 — intervention group
Group type: COMPARATOR
Intervention: Skin and RAST tests
Number of subjects: 30
Study 31287257 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined spinal-epidural anesthesia (CSEA)
Number of subjects: 95
Study 31287257 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia (GA)
Number of subjects: 95
Study 28847457 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-acting naltrexone
Number of subjects: 306
Study 25192689 — intervention group
Group type: EXPERIMENTAL
Intervention: Hamstring-tendon graft
Number of subjects: 40
Study 25192689 — intervention group
Group type: EXPERIMENTAL
Intervention: Patellar-tendon graft
Number of subjects: 40
Study 25192689 — intervention group
Group type: COMPARATOR
Intervention: Both graft types
Number of subjects: 40
Study 25192689 — intervention group
Group type: EXPERIMENTAL
Intervention: Patellar-tendon graft with rehabilitation
Number of subjects: 40
Study 22801937 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal estrogen therapy (estradiol, E(2)) with vaginal mesh prolapse surgery (VM)
Number of subjects: 448
Study 22801937 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal estrogen therapy (estradiol, E(2)) with minimally invasive sacral colpopexy (MISC)
Number of subjects: 448
Study 22801937 — intervention group
Group type: COMPARATOR
Intervention: Vaginal mesh prolapse surgery (VM) without vaginal estrogen therapy
Number of subjects: 448
Study 22801937 — intervention group
Group type: COMPARATOR
Intervention: Minimally invasive sacral colpopexy (MISC) without vaginal estrogen therapy
Number of subjects: 448
Study 21365652 — intervention group
Group type: EXPERIMENTAL
Intervention: supportive‐expressive psychotherapy
Number of subjects: 156
Study 21365652 — intervention group
Group type: EXPERIMENTAL
Intervention: medication
Number of subjects: 156
Study 21365652 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 156
Study 18642998 — intervention group
Group type: EXPERIMENTAL
Intervention: print‐based feedback
Number of subjects: 239
Study 18642998 — intervention group
Group type: EXPERIMENTAL
Intervention: telephone‐based feedback
Number of subjects: 239
Study 18642998 — intervention group
Group type: COMPARATOR
Intervention: contact control
Number of subjects: 239
Study 17699370 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 15030266 — intervention group
Group type: EXPERIMENTAL
Intervention: AGI‐1067
Number of subjects: 0
Study 10937510 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin glargine
Number of subjects: 426
Study 10937510 — intervention group
Group type: COMPARATOR
Intervention: NPH insulin
Number of subjects: 426
Study 8606694 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium carbonate (600 mg b.i.d. x 6 days)
Number of subjects: 12
Study 1413136 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil (6 g daily for four weeks)
Number of subjects: 9
Study 1413136 — intervention group
Group type: COMPARATOR
Intervention: Safflower oil (equivalent amounts to fish oil)
Number of subjects: 9
Study 31204333 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsule lycopene
Number of subjects: 60
Study 31204333 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsule lycopene and injection dexamethasone
Number of subjects: 60
Study 31204333 — intervention group
Group type: EXPERIMENTAL
Intervention: Injection dexamethasone and hyaluronidase
Number of subjects: 60
Study 29734362 — intervention group
Group type: EXPERIMENTAL
Intervention: Maxillary appliance
Number of subjects: 15
Study 29734362 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent use of appliances
Number of subjects: 15
Study 29734362 — intervention group
Group type: EXPERIMENTAL
Intervention: Maxillary appliance in an intermittent regimen
Number of subjects: 15
Study 26079108 — intervention group
Group type: EXPERIMENTAL
Intervention: Single vision lenses (SVLs)
Number of subjects: 469
Study 26079108 — intervention group
Group type: COMPARATOR
Intervention: Progressive addition lenses (PALs)
Number of subjects: 469
Study 26079108 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-progressing myopia)
Number of subjects: 469
Study 24483757 — intervention group
Group type: EXPERIMENTAL
Intervention: nifedipine 20 mg Q 8‐hourly
Number of subjects: 110
Study 24483757 — intervention group
Group type: COMPARATOR
Intervention: progesterone 400 mg daily
Number of subjects: 110
Study 22019244 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple kilovoltage (kV) and megavoltage (MV) imaging of implanted gold markers during treatment
Number of subjects: 108
Study 20873071 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge sharing practices with empowerment strategies (KSPES) program on antenatal education and postnatal support strategies
Number of subjects: 0
Study 20873071 — intervention group
Group type: COMPARATOR
Intervention: Standard knowledge of breastfeeding techniques (control group)
Number of subjects: 0
Study 18399897 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT)
Number of subjects: 0
Study 18399897 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous immunotherapy (SCIT)
Number of subjects: 0
Study 18399897 — intervention group
Group type: EXPERIMENTAL
Intervention: Both SLIT and SCIT
Number of subjects: 0
Study 16098253 — intervention group
Group type: EXPERIMENTAL
Intervention: LDCI 5‐FU 300 mg/m(2) per day for 28 days every 5 weeks
Number of subjects: 730
Study 16098253 — intervention group
Group type: COMPARATOR
Intervention: HDI 5‐FU 2,600 mg/m(2) for 24 hours each week
Number of subjects: 730
Study 12439085 — intervention group
Group type: EXPERIMENTAL
Intervention: Stationary cycling (BK)
Number of subjects: 10
Study 12439085 — intervention group
Group type: EXPERIMENTAL
Intervention: Weightlifting (WTS)
Number of subjects: 10
Study 12439085 — intervention group
Group type: COMPARATOR
Intervention: Nonexercise control day (Con)
Number of subjects: 10
Study 10511326 — intervention group
Group type: EXPERIMENTAL
Intervention: Fruit, Juice, and Vegetable Food Frequency Questionnaire (FFQ)
Number of subjects: 96
Study 10511326 — intervention group
Group type: EXPERIMENTAL
Intervention: Fruit, Juice, and Vegetable Food Recognition Form (FRF)
Number of subjects: 96
Study 10511326 — intervention group
Group type: COMPARATOR
Intervention: 24-hour dietary recalls (24hdr)
Number of subjects: 96
Study 7742151 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin (10-40 mg day-1 for three periods of 6 weeks)
Number of subjects: 24
Study 7742151 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin (10-40 mg day-1 for three periods of 6 weeks)
Number of subjects: 24
Study 7742151 — intervention group
Group type: COMPARATOR
Intervention: Simvastatin
Number of subjects: 24